Franco Noventa

2.3k total citations
19 papers, 1.7k citations indexed

About

Franco Noventa is a scholar working on Epidemiology, Hepatology and Internal Medicine. According to data from OpenAlex, Franco Noventa has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Hepatology and 4 papers in Internal Medicine. Recurrent topics in Franco Noventa's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (7 papers). Franco Noventa is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (8 papers) and Hepatitis C virus research (7 papers). Franco Noventa collaborates with scholars based in Italy, Spain and Netherlands. Franco Noventa's co-authors include G. Realdi, Giovanna Fattovich, Solko W. Schalm, Erik Christensen, J.M. Sánchez-Tapias, Maria Guido, G. Giustina, Stephanos J. Hadziyannis, A. Albertí and Lucia De Franceschi and has published in prestigious journals such as Hepatology, Gut and The American Journal of Medicine.

In The Last Decade

Franco Noventa

19 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franco Noventa Italy 13 1.3k 1.3k 196 118 109 19 1.7k
Marc Poliquin Canada 6 842 0.7× 658 0.5× 258 1.3× 126 1.1× 37 0.3× 12 1.0k
Sophie Hillaire France 14 1.3k 1.0× 889 0.7× 633 3.2× 66 0.6× 153 1.4× 36 1.7k
Fanny Turón Spain 23 1.4k 1.1× 1.3k 1.0× 727 3.7× 77 0.7× 79 0.7× 56 1.8k
Etsuko Hashimoto Japan 21 1.8k 1.4× 1.6k 1.3× 422 2.2× 206 1.7× 46 0.4× 55 2.3k
Jean-Pierre Benhamou France 13 1.5k 1.2× 1.4k 1.1× 354 1.8× 165 1.4× 114 1.0× 18 1.8k
Richard A. Willson United States 15 935 0.7× 593 0.5× 192 1.0× 345 2.9× 63 0.6× 26 1.4k
Ziv Ben‐Ari Israel 20 810 0.6× 627 0.5× 405 2.1× 77 0.7× 126 1.2× 57 1.2k
Xavier Causse France 14 614 0.5× 565 0.4× 98 0.5× 60 0.5× 120 1.1× 52 898
A. Iacobellis Italy 17 785 0.6× 751 0.6× 288 1.5× 24 0.2× 29 0.3× 44 1.1k
J.M. Sánchez-Tapias Spain 21 1.7k 1.3× 1.6k 1.3× 129 0.7× 176 1.5× 94 0.9× 27 2.0k

Countries citing papers authored by Franco Noventa

Since Specialization
Citations

This map shows the geographic impact of Franco Noventa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Noventa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Noventa more than expected).

Fields of papers citing papers by Franco Noventa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Noventa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Noventa. The network helps show where Franco Noventa may publish in the future.

Co-authorship network of co-authors of Franco Noventa

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Noventa. A scholar is included among the top collaborators of Franco Noventa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Noventa. Franco Noventa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bernardi, Enrico, Giuseppe Camporese, Cristiano Bortoluzzi, et al.. (2022). Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project. Life. 12(11). 1725–1725. 1 indexed citations
2.
Tormene, Daniela, Franco Noventa, Elena Campello, et al.. (2021). The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study. Internal and Emergency Medicine. 16(4). 997–1003. 3 indexed citations
3.
Zilio, Marialuisa, Linda Mazzai, Maria Teresa Sartori, et al.. (2015). A venous thromboembolism risk assessment model for patients with Cushing’s syndrome. Endocrine. 52(2). 322–332. 40 indexed citations
4.
Pengo, Vittorio, Marta Tonello, Franco Noventa, et al.. (2009). Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations. Thrombosis and Haemostasis. 101(4). 789–791. 9 indexed citations
5.
Bortolotti, Flavia, Maria Guido, S. Bartolacci, et al.. (2006). Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study. Hepatology. 43(3). 556–562. 154 indexed citations
6.
Bortolotti, Flavia, Massimo Resti, Matilde Marcellini, et al.. (2005). Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut. 54(6). 852–857. 26 indexed citations
7.
Marcolongo, R, Ivan Matteo Tavolini, Francesco Laveder, et al.. (2004). Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. The American Journal of Medicine. 116(3). 194–197. 101 indexed citations
8.
Grego, Franco, Sandro Lepidi, Pierfrancesco Bassi, et al.. (2003). Simultaneous surgical treatment of abdominal aortic aneurysm and carcinoma of the bladder. Journal of Vascular Surgery. 37(3). 607–614. 15 indexed citations
9.
Franceschi, Lucia De, Giovanna Fattovich, Franco Turrini, et al.. (2000). Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage. Hepatology. 31(4). 997–1004. 343 indexed citations
10.
11.
Bortolotti, Flavia, Paloma Jara, Loreto Hierro, et al.. (1998). Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. Journal of Hepatology. 29(2). 184–190. 96 indexed citations
12.
Benvegnù, Luisa, Franco Noventa, Liliana Chemello, Giovanna Fattovich, & A. Albertí. (1997). Prevalence and Incidence of Cholecystolithiasis in Cirrhosis and Relation to the Etiology of Liver Disease. Digestion. 58(3). 293–298. 30 indexed citations
13.
Fattovich, G., G. Giustina, Solko W. Schalm, et al.. (1995). Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B. Hepatology. 21(1). 77–82. 292 indexed citations
14.
Realdi, G., Giovanna Fattovich, Stephanos J. Hadziyannis, et al.. (1994). Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. Journal of Hepatology. 21(4). 656–666. 240 indexed citations
15.
Rugge, Massimo, M. Guido, Flavia Bortolotti, et al.. (1991). Histology and virus expression in the liver: A prognostic puzzle in chronic hepatitis B. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 419(2). 93–97. 2 indexed citations
16.
Tremolada, F., et al.. (1988). Blood-Transmitted and Clotting-Factor-Transmitted Non-A, Non-B Hepatitis. Journal of Clinical Gastroenterology. 10(4). 413–418. 9 indexed citations
17.
Diodati, G., Patrizia Pontisso, Paola Bonetti, et al.. (1988). Cryptogenic Chronic Liver Disease and Serum or Liver Hepatitis B Virus Markers. Digestion. 39(4). 251–256. 9 indexed citations
18.
Fattovich, Giovanna, Massimo Rugge, L. Brollo, et al.. (1986). Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type B. Hepatology. 6(2). 167–171. 222 indexed citations
19.
Fattovich, Giovanna, A. Albertí, Cinzia Crivellaro, et al.. (1983). Cellular immunity to the hepatitis B virion in acute hepatitis type B.. PubMed. 53(3). 645–50. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Poliquin Breakdown of academic impact, for papers by Sophie Hillaire Breakdown of academic impact, for papers by Fanny Turón Breakdown of academic impact, for papers by Etsuko Hashimoto Breakdown of academic impact, for papers by Jean-Pierre Benhamou Breakdown of academic impact, for papers by Richard A. Willson Breakdown of academic impact, for papers by Ziv Ben‐Ari Breakdown of academic impact, for papers by Xavier Causse Breakdown of academic impact, for papers by A. Iacobellis Breakdown of academic impact, for papers by J.M. Sánchez-Tapias
Rankless by CCL
2026